| Literature DB >> 28211512 |
Nikolaos Perakakis1, Georgios A Triantafyllou1, José Manuel Fernández-Real2,3, Joo Young Huh4, Kyung Hee Park5, Jochen Seufert6, Christos S Mantzoros1,7.
Abstract
Irisin is a myokine that leads to increased energy expenditure by stimulating the 'browning' of white adipose tissue. In the first description of this hormone, increased levels of circulating irisin, which is cleaved from its precursor fibronectin type III domain-containing protein 5, were associated with improved glucose homeostasis by reducing insulin resistance. Consequently, several studies attempted to characterize the role of irisin in glucose regulation, but contradictory results have been reported, and even the existence of this hormone has been questioned. In this Review, we present the current knowledge on the physiology of irisin and its role in glucose homeostasis. We describe the mechanisms involved in the synthesis, secretion, circulation and regulation of irisin, and the controversies regarding the measurement of irisin. We also discuss the direct effects of irisin on glucose regulatory mechanisms in different organs, the indirect effects and interactions with other hormones, and the important open questions with regard to irisin in those organs. Finally, we present the results from animal interventional studies and from human clinical studies investigating the association of irisin with obesity, insulin resistance, type 2 diabetes mellitus and the metabolic syndrome.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28211512 PMCID: PMC5878942 DOI: 10.1038/nrendo.2016.221
Source DB: PubMed Journal: Nat Rev Endocrinol ISSN: 1759-5029 Impact factor: 43.330